Related Experiment Video
Updated: Aug 19, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Adult hypertension: reducing cardiovascular morbidity and mortality
Insights
Thiazide diuretics are recommended as a first-line treatment for hypertension, including in patients with diabetes or a history of stroke. The primary goal of treatment is to reduce cardiovascular events and mortality.
Area of Science:
- Cardiology
- Pharmacology
- Internal Medicine
Background:
- Arterial hypertension management has evolved since 1999 with new data and antihypertensive drugs.
- The working definition of hypertension remains unchanged, requiring consistent readings of at least 160/95 mm Hg (or 140/80 mm Hg for specific patient groups).
Purpose of the Study:
- To review current treatments for arterial hypertension.
- To evaluate the risk-benefit balance of drug and non-drug interventions.
- To identify first-line and alternative antihypertensive therapies.
Main Methods:
- Review of published data and clinical endpoint trials.
- Assessment of antihypertensive drug efficacy and safety.
- Comparison of various drug classes including diuretics, beta-blockers, ACE inhibitors, and others.
Main Results:
- Thiazide diuretics (chlortalidone, hydrochlorothiazide) are supported as first-line treatment for most hypertensive patients.
- Beta-blockers and angiotensin-converting-enzyme inhibitors (ACE inhibitors) are identified as second-line alternatives.
- Other antihypertensives like calcium channel blockers and angiotensin II antagonists are available but less extensively evaluated than thiazides.
Conclusions:
- Antihypertensive therapy should prioritize reducing mortality and cardiovascular events over fixed blood pressure thresholds.
- Initiating treatment with a single drug is recommended when pharmacotherapy is necessary.
- Thiazide diuretics offer a favorable long-term risk-benefit profile for initial hypertension management.
Abstract:
(1) Since our last review of treatments for arterial hypertension in 1999 (Prescrire International no.41), many new data have been published and new antihypertensive drugs have appeared on the market. (2) The working definition of hypertension is unchanged, namely blood pressure of at least 160/95 mm Hg in the general population, and at least 140/80 mm Hg in patients with diabetes and a history of stroke; these figures must be found on several occasions using a standardised method, with the patient at rest. (3) The goals of antihypertensive therapy are to reduce mortality and cardiovascular events, and not simply to drive blood pressure below a fixed (and often controversial) threshold. (4) Some drug and non drug interventions have a positive risk-benefit balance in the long term. (5) When antihypertensive drug therapy is needed, trials based on clinical endpoints show that it is best to start treatment with a single drug. (6) New data support the use of certain thiazide diuretics (chlortalidone, or hydrochlorothiazide if chlortalidone is not available) as first line treatment for most hypertensive patients, including non diabetic adults, diabetic adults, elderly subjects (over 65 years), and stroke patients. Some betablockers and angiotensin-converting-enzyme inhibitors (ACE inhibitor) are second-line alternatives. (7) Assessment of other antihypertensive drugs has also progressed since 1999, including indapamide (thiazide-like diuretic), amlodipine, diltiazem and verapamil (calcium channel blockers), lisinopril (ACE inhibitor), and losartan and valsartan (angiotensin II antagonists). However, these drugs are not as thoroughly evaluated as thiazide diuretics, betablockers and some ACE inhibitors.
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension II: Pathophysiology
Hypertension V: Nursing Management
Hypertension I: Introduction